PathAI, a leader in digital and AI-powered pathology solutions, and Rede D’OR, the largest integrated healthcare network in Brazil, today announced a partnership that will bring PathAI’s cutting-edge technology to Rede D’Or’s network of hospitals and diagnostic centers, marking PathAI’s strategic entry into South America. Rede D’or will be the first major institution in Brazil to use digital pathology at scale.
Rede D’Or will implement PathAI’s AISight image management system across its pathology operations which support the national network of 78 hospitals. The platform integrates advanced AI algorithms, including PathAI’s AIM-Breast Biomarker panel supporting ER, PR, HER2, and Ki67 quantification, to support pathology workflows. Rede D’Or will also utilize PathAI’s tools for research purposes.
“This collaboration is a testament to Rede D’Or’s dedication to delivering world-class healthcare to our patients,” said Fernando Soares, MD, Full Professor at the University of Sao Paulo and Head of the Department of Anatomic Pathology at Rede D’Or. “We are looking forward to integrating AISight into our pathology workflows to enhance precision and efficiency, particularly in oncology, while advancing our research capabilities amidst our continued expansion.”
“This partnership demonstrates how leading healthcare institutions can successfully integrate digital and computational solutions to improve operational efficiency and advance research capabilities to deepen our understanding of diseases and refine treatment approaches,” said Andy Beck, MD, PhD, co-founder and CEO of PathAI. “Rede D’Or’s commitment to innovation in healthcare as a means to improve patient outcomes makes them the ideal partner for introducing our technology to the Latin American market.”
This implementation supports Rede D’Or’s R$7.5 billion expansion plan, which aims to grow their network to over 125 facilities.
